ES493702A0 - Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada - Google Patents

Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada

Info

Publication number
ES493702A0
ES493702A0 ES493702A ES493702A ES493702A0 ES 493702 A0 ES493702 A0 ES 493702A0 ES 493702 A ES493702 A ES 493702A ES 493702 A ES493702 A ES 493702A ES 493702 A0 ES493702 A0 ES 493702A0
Authority
ES
Spain
Prior art keywords
medicated
preparing
procedure
sequentially charged
cation exchanging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES493702A
Other languages
English (en)
Spanish (es)
Other versions
ES8106083A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES8106083A1 publication Critical patent/ES8106083A1/es
Publication of ES493702A0 publication Critical patent/ES493702A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES493702A 1979-07-26 1980-07-24 Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada Granted ES493702A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6093179A 1979-07-26 1979-07-26

Publications (2)

Publication Number Publication Date
ES8106083A1 ES8106083A1 (es) 1981-08-01
ES493702A0 true ES493702A0 (es) 1981-08-01

Family

ID=22032632

Family Applications (1)

Application Number Title Priority Date Filing Date
ES493702A Granted ES493702A0 (es) 1979-07-26 1980-07-24 Procedimiento para preparar una resina intercambiadora de cationes, medicada,secuencialmente cargada

Country Status (6)

Country Link
AU (1) AU5957480A (de)
DE (1) DE3028082A1 (de)
ES (1) ES493702A0 (de)
FR (1) FR2462162A1 (de)
GB (1) GB2055575A (de)
IT (1) IT1128534B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3719764A1 (de) * 1987-06-13 1988-12-22 Bayer Ag Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
US5419897A (en) * 1993-04-09 1995-05-30 Buckman Laboratories International, Inc. Ionene polymers as anthelmintics in animals
PL185332B1 (pl) * 1994-05-20 2003-04-30 Janssen Pharmaceutica Nv Kompozycja przeciwrobacza dla zwierząt towarzyszących człowiekowi zawierająca flubendazol
US7067116B1 (en) 2000-03-23 2006-06-27 Warner-Lambert Company Llc Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1
WO2002072069A1 (en) * 2001-03-12 2002-09-19 Novo Nordisk A/S Novel tablets and capsules and a process for its preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH383552A (de) * 1958-10-24 1964-10-31 Clinical Products Limited Verfahren zur Herstellung von Harz-Arzneistoffverbindungen
GB899720A (en) * 1960-08-15 1962-06-27 American Cyanamid Co Anthelmintic animal feed
US3177116A (en) * 1962-01-26 1965-04-06 American Cyanamid Co Anthelmintic compositions containing substituted styrylpyridinium compounds and method of administering same

Also Published As

Publication number Publication date
ES8106083A1 (es) 1981-08-01
FR2462162A1 (fr) 1981-02-13
IT1128534B (it) 1986-05-28
IT8049307A0 (it) 1980-07-23
AU5957480A (en) 1981-01-29
DE3028082A1 (de) 1981-02-19
GB2055575A (en) 1981-03-11

Similar Documents

Publication Publication Date Title
ES507972A0 (es) Un procedimiento para preparar compuestos de cefem .
AR224008A1 (es) Procedimiento para preparar polihidro-3,7-dimetil-8-(2-(tetrahidro-4-hidroxi-6-oxo-2h-piran-2-il)-etil)-1-naftil-2-metilbutirato
AR224186A1 (es) Procedimiento para preparar una hidantoina
AR227766A1 (es) Procedimiento para preparar nuevas pirixolo-1,5-a-pirimidinas sustituidas
ES245552Y (es) Cierre distribuidor para irrigacion,perfeccionado
AR230634A1 (es) Procedimiento para preparar una solucion para inyeccion
ES490166A0 (es) Un procedimiento para preparar mercaptoacildipeptidos
ES495520A0 (es) Un procedimiento para preparar una d-6-n-propilergolina
ES490686A0 (es) Un procedimiento para preparar una resina de fenol-formal- dehido modificada
AR227284A1 (es) Procedimiento para preparar antraceno-9,10-bis-carbonil-hidrazonas
MX6520E (es) Procedimiento para preparar un gel oftalmico de liberacion lenta
ES497303A0 (es) Un procedimiento para preparar 9-aminoalquilfluorenos
ES494530A0 (es) Procedimiento para preparar una composicion de catalizador
ES489689A0 (es) Procedimiento para preparar compuestos de isotiourea
ES492628A0 (es) Un procedimiento para la obtencion de una resina de petroleomodificada
ES492810A0 (es) Procedimiento para preparar una composicion de resina reso- lica de fenol-formaldehido
ES493499A0 (es) Procedimiento para preparar compuestos de 3-metilemazetidina
ES493798A0 (es) Un procedimiento para preparar 7-alcoxicarbonil-6,8-dime- til-4-hidroximetil-1-ftalazona
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
AR222235A1 (es) Una valvula de distribucion para servoconduccion
ES496859A0 (es) Un procedimiento para preparar derivados de halofenil-piri- dilalilamina
ES497795A0 (es) Procedimiento para preparar una composicion liberadora de fosfuro de hidrogeno
AR230953A1 (es) Procedimiento para preparar una nueva combinacion de farmacos
AR223521A1 (es) Un procedimiento para preparar una 3-alcoxi-6-alquilideno-hidrazinopiridazina
AR225482A1 (es) Procedimiento para preparar una sal de bencimidazolina